Protection against cisplatin ototoxicity by adenosine agonists

Biochemical Pharmacology

Volumn 67, Issue 9, 2004, Pages 1801-1807

  Whitworth, Craig A ^a   Ramkumar, Vickram ^a   Jones, Brett ^a   Tsukasaki, Naoki ^a   Rybak, Leonard P ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 chloro N cyclopentyladenosine; 8 cyclopentyl 1,3 dipropylxanthine; A 2 adenosine receptor; A1 adenosine receptor; A1AR; A2AR; CCPA; CGS; DPCPX; R phenylisopropyladenosine; R PIA

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 [4 [2 (4 CARBOXYETHYL)]PHENYLAMINO] 5' N ETHYLCARBOXAMIDOADENOSINE; 2 CHLORO N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A2 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR STIMULATING AGENT; CISPLATIN; GLUTATHIONE PEROXIDASE; LIPID PEROXIDASE; PHENYLISOPROPYLADENOSINE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUDITORY CORTEX; BRAIN STEM; CELL PROTECTION; CHINCHILLA; COCHLEA; CONTROLLED STUDY; DRUG EFFECT; EAR PROTECTION; HAIR CELL; HEARING LOSS; LIPID PEROXIDATION; MALE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPE;

ADENOSINE; ANIMALS; ANTINEOPLASTIC AGENTS; CHINCHILLA; CISPLATIN; COCHLEA; DISEASE MODELS, ANIMAL; HEARING DISORDERS; LIPID PEROXIDATION; MALE; NEUROPROTECTIVE AGENTS; PHENETHYLAMINES; RECEPTORS, PURINERGIC P1;

EID: 1842735378     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.01.010     Document Type: Article

References (34)

1. Rybak L.P. Cis-platinum associated hearing loss. J. Laryngol. Otol. 95(7):1981;745-747.
2. Fausti S.A., Frey R.H., Henry J.A., Olson D.J., Schaffer H.I. High-frequency testing techniques and instrumentation for early detection of ototoxicity. J. Rehabil. Res. Dev. 30(3):1993;333-341.
3. Helson L., Okonkwo E., Anton L., Cvitkovic E. Cis-platinum ototoxicity. Clin. Toxicol. 13(4):1978;469-478.
4. Ravi R., Somani S.M., Rybak L.P. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol. Toxicol. 76(6):1995;386-394.
5. Ravi R., Rybak L.P., Hoffman D., Whitworth C., Scott V. Diethyldithiocarbamate protects against cisplatin ototoxicity and nephrotoxicity. Otolaryngol. Head Neck Surg. 107:1992;232-237.
6. Rybak L.P., Husain K., Evenson L., Morris C., Whitworth C., Somani S.M. Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system. Pharmacol. Toxicol. 81:1997;173-179.
7. Rybak L.P., Husain K., Morris C., Whitworth C.A., Somani S. Effect of protective agents against cisplatin ototoxicity. Am. J. Otol. 21:2000;513-520.
8. Husain K., Morris C., Whitworth C., Trammell G.L., Rybak L.P., Somani S.M. Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system. Mol. Cell Biochem. 178:1998;127-133.
9. Rybak L.P., Ravi R., Somani S.M. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fundam. Appl. Toxicol. 26(2):1995;293-300.
10. Korver K, Rybak LP, Whitworth C, Campbell KCM. Round window application of D-methionine provides complete cisplatin otoprotection. Otolaryngol Head Neck Surg 126(6):683-9.
11. Whitworth CA, Ramkumar V, Jones B, Tsukasaki N, Rybak LP. Protection against cisplatin ototoxicity by the adenosine agonist R-PIA: a round window application study. Presented at the 24th Annual Midwinter Meeting of the Association for Research in Otolaryngology, Abstract 547, February 4-8, 2001.
12. Hu B.H., Zheng X.Y., McFadden S.L., Kopke R.D., Henderson D. R-Phenylisopropyladenosine attenuates noise-induced hearing loss in the chinchilla. Hear Res. 113(1/2):1997;198-206.
13. Henderson D., McFadden S.L., Liu C.C., Hight N., Zheng X.Y. The role of antioxidants in protection from impulse noise. Ann. N.Y. Acad. Sci. 884:1999;368-380.
14. Tabuchi K., Ito Z., Wada T., Takahashi K., Hara A., Kusakari J. Effect of A1 adenosine receptor agonist upon cochlear dysfunction induced by transient ischemia. Hear Res. 36(1/2):1999;86-90.
15. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50:1998;413-492.
16. Ford M.S., Maggirwar S.B., Rybak L.P., Whitworth C., Ramkumar V. Expression and function of adenosine receptors in the chinchilla cochlea. Hear Res. 105(1/2):1997;130-140.
17. Ramkumar V., Ravi R., Wilson M.C., Gettys T.W., Whitworth C., Rybak L.P. Identification of A1 adenosine receptors in rat cochlea coupled to inhibition of adenylyl cyclase. Am. J. Physiol. 267(3 Pt 1):1994;C731-C737.
18. Ford M.S., Nie Z., Whitworth C., Rybak L.P., Ramkumar V. Up-regulation of adenosine receptors in the cochlea by cisplatin. Hear Res. 111(1/2):1997;143- 152.
19. Janning M.H., Whitworth C.A., Rybak L.P. An experimental model of cisplatin ototoxicity in chinchillas. Otolaryngol. Head Neck Surg. 119(6):1998;574-580.
20. Nie Z., Mei Y., Ford M., Rybak L., Marcuzzi A., Ren H., Stiles G.L., Ramkumar V. Oxidative stress increases A1 adenosine receptor expression by activating nuclear factor kappa B. Mol. Pharmacol. 53(4):1998;663-669.
21. Ramkumar V, Whitworth CA, Hughes LF, Rybak LP. Noise conditioning and A1 adenosine receptor regulation in the chinchilla inferior colliculus. Presented at the 24th Annual Midwinter Meeting of the Association for Research in Otolaryngology, Abstract 974, February 4-8, 2001.
22. Swain S.D., Siemsen D.W., Nelson L.K., Sipes K.M., Hanson A.J., Quinn M.T. Inhibition of the neutrophil NADPH oxidase by adenosine is associated with increased movement of flavocytochrome b between subcellular fractions. Inflammation. 27(1):2003;45-58.
23. Narayan P., Mentzer R.M. Jr., Lasley R.D. Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes. J. Mol. Cell Cardiol. 33(1):2001;121-129.
24. Salt A.N., Ma Y. Quantification of solute entry into cochlear perilymph through the round window membrane. Hear Res. 154(1/2):2001;88-97.
25. Kelly T.C., Whitworth C.A., Husain K., Rybak L. Aminoguanidine reduces cisplatin ototoxicity. Hear Res. 86(1/2):2003;10-16.
26. Sha S.H., Taylor R., Forge A., Schacht J. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res. 155(1/2):2001;1-8.
27. Tsukasaki N., Whitworth C.A., Rybak L.P. Acute changes in cochlear potentials due to cisplatin. Hear Res. 149:2000;189-198.
28. Laurell G., Andersson A., Engstrom B., Ehrsson H. Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig. Cancer Chemother Pharmacol. 36(1):1995;83-86.
29. Munoz D.J., McFie C., Thorne P.R. Modulation of cochlear blood flow by extracellular purines. Hear Res. 127(1/2):1999;55-61.
30. Cunha R.A., Johansson B., van der Ploeg I., Sebastiao A.M., Ribeiro J.A., Fredholm B.B. Evidence for functionally important adenosine A2a receptors in the rat hippocampus. Brain Res. 649(1/2):1994;208-216.
31. Dixon A.K., Widdowson L., Richardson P.J. Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum. J. Neurochem. 69(1):1997;315-321.
32. Juhn S.K., Hamaguchi Y., Goycoolea M. Review of round window membrane permeability. Acta Otolaryngol. Suppl. 457:1989;43-48.
33. Okuno T., Nomura Y. Permeability of the round window membrane. Arch Otorhinolaryngol. 240(2):1984;103-106.
34. Juhn S.K., Edlin J., Jung T.T., Giebink G.S. The kinetics of penicillin diffusion in serum and middle ear effusions in experimentally induced otitis media. Arch Otorhinolaryngol. 243(3):1986;183-185.